Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) : Xuebijing injection has submitted an application for clinical study registration to FDA

Every AI express, investors ask questions on the investor interaction platform: what is the progress of your Xuebijing products in foreign FDA clinical trials? I hope to give full play to the power of traditional Chinese medicine in the global anti epidemic as soon as possible.

Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) ( Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) . SZ) said on the investor interaction platform on April 2 that Xuebijing injection had submitted an application for registration of clinical research to FDA.

- Advertisment -